Earnings Releases·Oct 29, 2026, 8:00 AM ET

Integer Holdings Corporation — Third Quarter 2026 Earnings Summary

Q3 2026 total sales declined 3.9% year-over-year to $450 million, with non-GAAP adjusted operating income and EPS falling 23% and 25% respectively; nine-month sales decreased 2.0% to $1.35 billion.
The company is withholding financial guidance and will not host a conference call due to its pending acquisition by a KKR affiliate, which is anticipated to close by the end of 2026.
Cardio & Vascular sales dropped 5% in the quarter, while Cardiac Rhythm Management & Neuromodulation grew 4%; total debt increased $34 million to $1.219 billion, resulting in a leverage ratio of 3.3x adjusted EBITDA.
Shareholders approved the merger agreement on October 21, 2026, following early HSR waiting period termination, and the company executed $50 million in common stock repurchases during the nine-month period.